四川省维克奇生物科技有限公司，是一家专业从事中药对照品及植物有效成分化合物的分离、提纯生产、销售为一体的高技术企业。
      公司技术实力雄厚, 拥有一批高素质的科研队伍，具备很强的技术开发和研发能力，在植物有效成分化合物的研究、生产及植物有效成分化合物创新等方面有很丰富的技术储备和经验，并掌握着其先进的理论原理和实施方法。更有效地着力于新品种的深度开发，拓展应用市场，推动植物有效成分化合物研发的产业化进程。目前，我公司与多家科研院所、医药院校和制药企业建立起了长期的合作关系，拥有远志系列；人参皂苷系列；柴胡皂苷系列；重楼皂苷系列；川芎系列；肉苁蓉系列；五味子系列；大黄系列；丹参系列；奎宁酸系列；甘草系列等100余个系列700多个品种,产品远销美国、英国、德国、韩国、日本、荷兰、比利时、法国，俄罗斯、澳大利亚、新西兰等国家和地区。在市场竞争日趋激烈的今天，我们将一如既往地秉承“一切为了满足客户的需求”的经营宗旨；牢固树立“以客户需求为准则、以市场需求为导向，不断开发高质量的新产品，提供客户满意的综合服务质量”的方针。
    我们愿与您精诚合作，共创美好的未来。     

    Sichuan Weikeqi Biological Technology Co., Ltd. is a high-tech enterprise dealt in separating, purifying, selling of chemical reference substance ａnd plant effective constituent compound.
    Our company is strong in technology. It has one high-quality scientific research team with strong technological development ａnd research ability.  In research, manufacturing, ａnd innovation of plant effective constituent compound, it has abundant technical storage ａnd is very experienced. It has also mastered advanced theory, principle ａnd implementing method, especially effectively exerted itself to deeply exploit new variety, develop applicable market, ａnd propel industrialization of effective constituent compound research ａnd development. At present, our company has established long partnership with many scientific research stations ａnd institutes, medicine schools ａnd colleges ａnd pharmaceutical enterprises. We have products of more than 700varieties, which are sold to countries far away like America, Great Britain, Germany, Korean, Japan, Netherlands, Belgium, France, Russia, Australia, New Zealand, etc. With competition in market is becoming increasingly fierce today, we will continue sticking to our business tenet of “all is to satisfy customer’s needs”, ａnd will firmly establish guideline of “based on customer’s needs ａnd oriented to market demand, continue developing new high-quality products ａnd provide customer satisfied integrated service quality”
     We wish to cooperate with you sincerely ａnd create bright future together.